Seminars in Hematology

Papers
(The H4-Index of Seminars in Hematology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Special issue on chronic lymphocytic leukemia: Prognostication and therapeutic options introductory editorial78
CAR T-cell therapy comes of age: Introductory editorial for the special issue57
Clinical applications of circulating tumor DNA in Hodgkin lymphoma52
Insights from the 12th International Workshop on Waldenstrom's Macroglobulinemia50
Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation49
How to set up a clinical research center in Brazil, as an example of a middle-income country41
Extramedullary myeloma in the era of CAR T-cell and bispecific antibody therapies41
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-1925
Epidemiology and etiology of diffuse large B-cell lymphoma24
Lessons learned from the Eµ-TCL1 mouse model of CLL21
The future of lymphoma diagnosis, prognosis, and treatment monitoring in countries with limited access to pathology services21
TET2 mutation as prototypic clonal hematopoiesis lesion20
Somatic mutations in “benign” blood diseases19
Antibody and immunotherapy in diffuse large B-cell lymphoma18
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence17
The role of viruses in HIV-associated lymphomas17
0.030141115188599